Rain Oncology
Presence
Rain Oncology is a company listed under the stock ticker RAIN (US).
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Rain Oncology
- Avanish Vellanki, Chief Executive Officer and Chairman of the Board
- Stefani Wolff, Director
- Peter Radovich, Director
Create your alert
to follow the executive moves at Rain Oncology.
Biotechnology
Rain Oncology has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Rain Oncology
- Press Release: Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
- Press Release: Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
- News & Press Releases
- Press Release: Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- News & Press Releases
- Press Release: Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023
- News & Press Releases
- News & Press Releases
- News & Press Releases
- Press Release: Rain Oncology Provides Company Update and Outlines Strategic Priorities of Milademetan Clinical Programs
- View more press releases Close
Social media about Rain Oncology
- Rain Oncology on Wikipedia, Google News & Yahoo Finance
- Rain Oncology on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Avanish Vellanki 
Call Rain Oncology at +1 510...
